| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.765 | 0.016 | 0.765 | Caspase 9 stimulant | 0.433 0.092 CID_101650227 0.48 0.068 CID_101650225 | ||
| 0.641 | 0.014 | 0.641 | Aldehyde oxidase inhibitor | 0.476 0.036 CID_101650227 0.165 0.127 CID_101650225 | ||
| 0.608 | 0.007 | 0.64 | Anticonvulsant | 0.64 0.005 CID_101650227 | CID_101650227 | |
| 0.55 | 0.004 | 0.55 | Nav1.2 sodium channel blocker | 0.275 0.018 CID_101650227 0.174 0.045 CID_101650225 | ||
| 0.512 | 0.004 | 0.512 | Nav1.3 sodium channel blocker | 0.255 0.013 CID_101650227 0.149 0.049 CID_101650225 | ||
| 0.508 | 0.003 | 0.508 | Nav1.6 sodium channel blocker | 0.291 0.006 CID_101650227 0.198 0.02 CID_101650225 | ||
| 0.496 | 0.004 | 0.496 | Calcium channel blocker | 0.466 0.004 CID_101650227 0.276 0.013 CID_101650225 | ||
| 0.49 | 0.005 | 0.49 | 5 Hydroxytryptamine 2B antagonist | 0.217 0.024 CID_101650227 0.149 0.041 CID_101650225 | ||
| 0.498 | 0.023 | 0.498 | Spasmolytic | 0.316 0.064 CID_101650227 0.178 0.138 CID_101650225 | ||
| 0.449 | 0.005 | 0.449 | 5 Hydroxytryptamine 2C antagonist | 0.175 0.021 CID_101650227 0.119 0.037 CID_101650225 | ||
| 0.454 | 0.048 | 0.454 | Histamine release inhibitor | 0.299 0.124 CID_101650227 | ||
| 0.413 | 0.009 | 0.413 | 5 Hydroxytryptamine 2 antagonist | 0.165 0.039 CID_101650227 0.107 0.067 CID_101650225 | ||
| 0.421 | 0.029 | 0.421 | Vasodilator, coronary | 0.29 0.096 CID_101650227 0.229 0.155 CID_101650225 | ||
| 0.407 | 0.015 | 0.407 | Cyclic AMP phosphodiesterase inhibitor | 0.193 0.099 CID_101650227 0.154 0.145 CID_101650225 | ||
| 0.372 | 0.008 | 0.372 | Anesthetic local | 0.169 0.041 CID_101650227 0.111 0.074 CID_101650225 | ||
| 0.361 | 0.007 | 0.361 | Butyrylcholinesterase inhibitor | 0.167 0.028 CID_101650227 0.154 0.033 CID_101650225 | ||
| 0.358 | 0.005 | 0.358 | 5 Hydroxytryptamine 1F antagonist | 0.154 0.016 CID_101650227 0.07 0.05 CID_101650225 | ||
| 0.361 | 0.008 | 0.361 | 5 Hydroxytryptamine 2A antagonist | 0.128 0.035 CID_101650227 0.086 0.055 CID_101650225 | ||
| 0.345 | 0.003 | 0.345 | Sphingomyelinase inhibitor | 0.206 0.009 CID_101650227 0.165 0.019 CID_101650225 | ||
| 0.345 | 0.016 | 0.345 | Ca(v)3.3 blocker | 0.318 0.029 CID_101650227 0.255 0.094 CID_101650225 | ||
| 0.33 | 0.005 | 0.416 | Histamine H1 receptor antagonist | 0.416 0.004 CID_101650227 0.095 0.044 CID_101650225 | CID_101650227 | |
| 0.327 | 0.005 | 0.327 | Calcium channel (voltage-sensitive) blocker | 0.261 0.009 CID_101650227 0.108 0.073 CID_101650225 | ||
| 0.324 | 0.011 | 0.439 | Antipruritic | 0.439 0.005 CID_101650227 0.156 0.087 CID_101650225 | CID_101650227 | |
| 0.311 | 0.004 | 0.311 | Photosensitizer | 0.182 0.017 CID_101650227 0.146 0.033 CID_101650225 | ||
| 0.308 | 0.003 | 0.308 | Histamine N-methyltransferase inhibitor | 0.167 0.009 CID_101650227 0.14 0.018 CID_101650225 | ||
| 0.312 | 0.008 | 0.312 | Nav1.1 sodium channel blocker | 0.2 0.019 CID_101650227 0.15 0.033 CID_101650225 | ||
| 0.342 | 0.039 | 0.393 | HERG channel blocker | 0.285 0.053 CID_101650227 0.393 0.029 CID_101650225 | CID_101650225 | |
| 0.34 | 0.04 | 0.34 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.231 0.125 CID_101650227 | ||
| 0.307 | 0.012 | 0.307 | NADPH oxidase inhibitor | 0.107 0.101 CID_101650225 | ||
| 0.299 | 0.004 | 0.299 | Calcium channel L-type blocker | 0.21 0.005 CID_101650227 0.105 0.022 CID_101650225 | ||
| 0.303 | 0.01 | 0.391 | Antihistaminic | 0.391 0.006 CID_101650227 | CID_101650227 | |
| 0.329 | 0.036 | 0.329 | Psychostimulant | 0.326 0.036 CID_101650227 | ||
| 0.299 | 0.009 | 0.299 | Alpha 2b adrenoreceptor antagonist | 0.141 0.043 CID_101650227 0.124 0.055 CID_101650225 | ||
| 0.292 | 0.01 | 0.351 | Histamine antagonist | 0.351 0.008 CID_101650227 | CID_101650227 | |
| 0.328 | 0.046 | 0.352 | Cardiotonic | 0.352 0.039 CID_101650227 | CID_101650227 | |
| 0.298 | 0.019 | 0.298 | 5 Hydroxytryptamine antagonist | 0.115 0.068 CID_101650227 | ||
| 0.28 | 0.016 | 0.28 | Adenylate cyclase inhibitor | 0.136 0.055 CID_101650227 | ||
| 0.276 | 0.013 | 0.276 | Dopamine antagonist | 0.245 0.015 CID_101650227 0.072 0.053 CID_101650225 | ||
| 0.269 | 0.007 | 0.269 | Dopamine D3 antagonist | 0.118 0.02 CID_101650227 0.081 0.032 CID_101650225 | ||
| 0.26 | 0.007 | 0.26 | Calcium antagonist | 0.148 0.023 CID_101650227 0.093 0.053 CID_101650225 | ||
| 0.257 | 0.012 | 0.257 | 5 Hydroxytryptamine 1 antagonist | 0.073 0.051 CID_101650227 | ||
| 0.327 | 0.084 | 0.348 | Vasodilator, peripheral | 0.348 0.075 CID_101650227 | CID_101650227 | |
| 0.287 | 0.048 | 0.287 | Amyloid beta aggregation inhibitor | |||
| 0.347 | 0.11 | 0.427 | Analgesic | 0.427 0.073 CID_101650225 | CID_101650225 | |
| 0.313 | 0.079 | 0.313 | Calcium channel activator | 0.291 0.101 CID_101650227 0.25 0.147 CID_101650225 | ||
| 0.287 | 0.054 | 0.319 | Potassium channel (Voltage-sensitive) blocker | 0.237 0.074 CID_101650227 0.319 0.044 CID_101650225 | CID_101650225 | |
| 0.244 | 0.011 | 0.244 | 5 Hydroxytryptamine 1A antagonist | 0.073 0.044 CID_101650227 | ||
| 0.24 | 0.009 | 0.24 | 5 Hydroxytryptamine 7 antagonist | 0.117 0.022 CID_101650227 0.06 0.045 CID_101650225 | ||
| 0.254 | 0.024 | 0.254 | Acetylcholine M1 receptor antagonist | 0.159 0.067 CID_101650227 | ||
| 0.3 | 0.079 | 0.3 | Caspase 3 stimulant | |||
| 0.235 | 0.018 | 0.235 | ATPase inhibitor | 0.181 0.057 CID_101650227 | ||
| 0.226 | 0.014 | 0.226 | Dopamine D2 antagonist | 0.225 0.014 CID_101650227 | ||
| 0.265 | 0.059 | 0.265 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.202 | 0.006 | 0.202 | Heat shock protein 70 antagonist | 0.156 0.034 CID_101650227 0.147 0.053 CID_101650225 | ||
| 0.273 | 0.077 | 0.273 | Insulysin inhibitor | 0.203 0.152 CID_101650227 | ||
| 0.26 | 0.067 | 0.26 | Antiamyloidogenic | |||
| 0.194 | 0.004 | 0.194 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 CID_101650227 0.178 0.008 CID_101650225 | ||
| 0.202 | 0.018 | 0.202 | Alpha 2c adrenoreceptor antagonist | 0.086 0.08 CID_101650227 | ||
| 0.199 | 0.017 | 0.199 | Calcium channel N-type blocker | 0.187 0.02 CID_101650227 | ||
| 0.202 | 0.024 | 0.202 | Acetylcholine muscarinic antagonist | 0.141 0.05 CID_101650227 | ||
| 0.184 | 0.006 | 0.184 | Histamine H2 receptor antagonist | 0.121 0.02 CID_101650227 0.086 0.053 CID_101650225 | ||
| 0.187 | 0.009 | 0.187 | 5 Hydroxytryptamine 1B antagonist | 0.069 0.042 CID_101650227 | ||
| 0.201 | 0.027 | 0.201 | Alpha adrenoreceptor antagonist | |||
| 0.197 | 0.027 | 0.667 | DNA intercalator | 0.094 0.08 CID_101650227 0.667 0.004 CID_101650225 | CID_101650225 | |
| 0.185 | 0.016 | 0.185 | Alpha 1b adrenoreceptor antagonist | 0.067 0.055 CID_101650227 | ||
| 0.176 | 0.012 | 0.176 | Alpha 1d adrenoreceptor antagonist | 0.06 0.041 CID_101650227 | ||
| 0.184 | 0.021 | 0.212 | Sphingosine 1-phosphate receptor 5 antagonist | 0.212 0.007 CID_101650227 0.131 0.097 CID_101650225 | CID_101650227 | |
| 0.299 | 0.137 | 0.299 | MAP kinase kinase 6 inhibitor | |||
| 0.284 | 0.125 | 0.284 | Calpain 2 inhibitor | |||
| 0.172 | 0.012 | 0.172 | Dopamine D1 antagonist | 0.061 0.049 CID_101650227 0.063 0.047 CID_101650225 | ||
| 0.165 | 0.006 | 0.165 | 5 Hydroxytryptamine 5A antagonist | 0.083 0.022 CID_101650227 | ||
| 0.176 | 0.02 | 0.34 | Mediator release inhibitor | 0.34 0.006 CID_101650227 | CID_101650227 | |
| 0.175 | 0.02 | 0.175 | Protein kinase C gamma inhibitor | 0.132 0.044 CID_101650227 | ||
| 0.161 | 0.007 | 0.161 | 5 Hydroxytryptamine 5 antagonist | 0.072 0.025 CID_101650227 | ||
| 0.183 | 0.037 | 0.183 | Cholinergic antagonist | 0.112 0.082 CID_101650227 | ||
| 0.229 | 0.083 | 0.229 | Vasodilator | 0.158 0.145 CID_101650227 | ||
| 0.184 | 0.038 | 0.184 | Acetylcholinesterase inhibitor | |||
| 0.168 | 0.026 | 0.168 | Alpha 1 adrenoreceptor antagonist | |||
| 0.152 | 0.011 | 0.152 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 CID_101650227 0.102 0.053 CID_101650225 | ||
| 0.161 | 0.02 | 0.161 | Alpha 2a adrenoreceptor antagonist | |||
| 0.209 | 0.07 | 0.209 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.182 | 0.047 | 0.182 | MAO inhibitor | 0.154 0.059 CID_101650227 | ||
| 0.16 | 0.026 | 0.16 | Ca(v)2.2 blocker | 0.094 0.053 CID_101650227 | ||
| 0.185 | 0.054 | 0.185 | Cholinergic | |||
| 0.17 | 0.04 | 0.17 | Acetylcholine antagonist | 0.106 0.085 CID_101650227 | ||
| 0.201 | 0.072 | 0.201 | Insulin sensitizer | |||
| 0.167 | 0.038 | 0.167 | Adenylate cyclase stimulant | 0.128 0.106 CID_101650227 | ||
| 0.141 | 0.012 | 0.141 | Acetylcholine M4 receptor antagonist | 0.093 0.034 CID_101650227 | ||
| 0.128 | 0.003 | 0.128 | Adenylate cyclase 1 inhibitor | 0.087 0.006 CID_101650227 0.07 0.012 CID_101650225 | ||
| 0.211 | 0.086 | 0.255 | Potassium channel blocker | 0.255 0.064 CID_101650227 0.161 0.124 CID_101650225 | CID_101650227 | |
| 0.148 | 0.023 | 0.148 | Nitric-oxide synthase inhibitor | |||
| 0.147 | 0.027 | 0.147 | Protein kinase C mu inhibitor | |||
| 0.139 | 0.025 | 0.139 | Alpha 1a adrenoreceptor antagonist | |||
| 0.239 | 0.126 | 0.384 | Thyroid hormone beta antagonist | 0.384 0.058 CID_101650227 | CID_101650227 | |
| 0.128 | 0.017 | 0.128 | Glutamate release inhibitor | 0.083 0.081 CID_101650225 | ||
| 0.201 | 0.09 | 0.201 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.133 | 0.023 | 0.275 | Telomerase inhibitor | 0.203 0.013 CID_101650227 0.275 0.008 CID_101650225 | CID_101650225 | |
| 0.238 | 0.131 | 0.385 | Thyroid hormone antagonist | 0.385 0.06 CID_101650227 | CID_101650227 | |
| 0.212 | 0.106 | 0.436 | DNA damaging | 0.268 0.071 CID_101650227 0.436 0.021 CID_101650225 | CID_101650225 | |
| 0.112 | 0.006 | 0.258 | Kinesin antagonist | 0.056 0.015 CID_101650227 0.258 0.004 CID_101650225 | CID_101650225 | |
| 0.112 | 0.006 | 0.258 | Kinesin-like protein 1 inhibitor | 0.056 0.015 CID_101650227 0.258 0.004 CID_101650225 | CID_101650225 | |
| 0.146 | 0.042 | 0.146 | MAO A inhibitor | 0.136 0.046 CID_101650227 | ||
| 0.131 | 0.028 | 0.131 | Alcohol dehydrogenase inhibitor | 0.111 0.042 CID_101650227 | ||
| 0.237 | 0.135 | 0.237 | Cholesterol antagonist | |||
| 0.129 | 0.027 | 0.129 | Protein kinase C zeta inhibitor | 0.093 0.06 CID_101650227 | ||
| 0.121 | 0.019 | 0.154 | Cannabinoid receptor agonist | 0.154 0.013 CID_101650227 | CID_101650227 | |
| 0.176 | 0.075 | 0.176 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.154 | 0.055 | 0.154 | MAP3K9 inhibitor | 0.121 0.112 CID_101650227 | ||
| 0.118 | 0.021 | 0.245 | 5 Hydroxytryptamine uptake inhibitor | 0.065 0.042 CID_101650227 0.245 0.008 CID_101650225 | CID_101650225 | |
| 0.186 | 0.09 | 0.186 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.126 CID_101650227 | ||
| 0.151 | 0.055 | 0.213 | Toll-Like receptor antagonist | 0.213 0.026 CID_101650227 | CID_101650227 | |
| 0.106 | 0.011 | 0.106 | Protein kinase C beta inhibitor | 0.073 0.042 CID_101650227 | ||
| 0.138 | 0.044 | 0.18 | DNA repair enzyme inhibitor | 0.18 0.014 CID_101650225 | CID_101650225 | |
| 0.11 | 0.019 | 0.11 | 5 Hydroxytryptamine 1D antagonist | 0.062 0.046 CID_101650227 | ||
| 0.125 | 0.035 | 0.125 | Alpha 2 adrenoreceptor antagonist | |||
| 0.105 | 0.016 | 0.105 | Acetylcholine M5 receptor antagonist | 0.055 0.05 CID_101650227 | ||
| 0.099 | 0.014 | 0.099 | CC chemokine 2 receptor antagonist | 0.072 0.023 CID_101650227 | ||
| 0.107 | 0.024 | 0.107 | Interferon agonist | 0.089 0.039 CID_101650227 | ||
| 0.094 | 0.011 | 0.094 | Potassium channel (Ca-activated) blocker | 0.074 0.023 CID_101650227 | ||
| 0.127 | 0.045 | 0.127 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.106 | 0.024 | 0.106 | Dopamine D4 antagonist | |||
| 0.09 | 0.012 | 0.09 | Potassium channel intermediate-conductance Ca-activated blocker | 0.064 0.035 CID_101650227 | ||
| 0.198 | 0.122 | 0.198 | Neuropeptide Y2 antagonist | |||
| 0.125 | 0.049 | 0.125 | Nav1.5 sodium channel blocker | |||
| 0.092 | 0.017 | 0.092 | 5 Hydroxytryptamine 6 antagonist | 0.058 0.038 CID_101650227 | ||
| 0.094 | 0.02 | 0.094 | Cannabinoid CB2 receptor agonist | 0.059 0.035 CID_101650227 | ||
| 0.142 | 0.069 | 0.142 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.092 | 0.019 | 0.092 | Protein kinase C eta inhibitor | 0.062 0.033 CID_101650227 | ||
| 0.116 | 0.044 | 0.116 | Potassium channel (Ca-activated) activator | |||
| 0.18 | 0.109 | 0.18 | Hypolipemic | |||
| 0.093 | 0.022 | 0.152 | Cannabinoid CB1 receptor agonist | 0.152 0.01 CID_101650227 | CID_101650227 | |
| 0.21 | 0.14 | 0.21 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.117 | 0.047 | 0.117 | Antiadrenergic | |||
| 0.165 | 0.096 | 0.177 | P-glycoprotein inhibitor | 0.177 0.083 CID_101650227 | CID_101650227 | |
| 0.187 | 0.12 | 0.187 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.145 | 0.079 | 0.145 | Cytidine deaminase inhibitor | |||
| 0.071 | 0.005 | 0.106 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.059 0.008 CID_101650227 0.106 0.004 CID_101650225 | CID_101650225 | |
| 0.102 | 0.038 | 0.102 | Acetylcholine nicotinic antagonist | |||
| 0.103 | 0.039 | 0.103 | Neuropeptide Y antagonist | |||
| 0.136 | 0.072 | 0.196 | Toll-Like receptor 9 antagonist | 0.196 0.037 CID_101650227 | CID_101650227 | |
| 0.088 | 0.025 | 0.088 | Acetylcholine M2 receptor antagonist | 0.061 0.044 CID_101650227 | ||
| 0.07 | 0.007 | 0.077 | Benzodiazepine antagonist | 0.077 0.005 CID_101650227 | CID_101650227 | |
| 0.099 | 0.036 | 0.099 | Hematopoietic | 0.088 0.052 CID_101650227 | ||
| 0.093 | 0.031 | 0.093 | Ca(v)3.1 blocker | 0.087 0.041 CID_101650227 | ||
| 0.115 | 0.053 | 0.115 | MAO B inhibitor | |||
| 0.11 | 0.048 | 0.11 | Adrenaline antagonist | |||
| 0.072 | 0.012 | 0.072 | Potassium channel small-conductance Ca-activated blocker | 0.044 0.032 CID_101650227 | ||
| 0.092 | 0.034 | 0.092 | CC chemokine 5 receptor agonist | 0.079 0.068 CID_101650227 | ||
| 0.078 | 0.021 | 0.078 | Sigma receptor antagonist | 0.054 0.032 CID_101650227 | ||
| 0.07 | 0.015 | 0.07 | Dopamine D5 antagonist | 0.047 0.028 CID_101650225 | ||
| 0.079 | 0.025 | 0.079 | Interferon inducer | 0.066 0.041 CID_101650227 | ||
| 0.084 | 0.033 | 0.084 | Potassium channel large-conductance Ca-activated activator | |||
| 0.08 | 0.03 | 0.084 | Histone deacetylase inhibitor | 0.084 0.027 CID_101650227 | CID_101650227 | |
| 0.098 | 0.048 | 0.098 | Polo-like kinase-1 inhibitor | |||
| 0.115 | 0.068 | 0.115 | Interleukin 8 antagonist | |||
| 0.057 | 0.01 | 0.057 | Histamine H1 receptor agonist | 0.049 0.02 CID_101650227 | ||
| 0.073 | 0.026 | 0.073 | Calcium channel T-type blocker | 0.054 0.047 CID_101650227 | ||
| 0.054 | 0.007 | 0.099 | ATM kinase inhibitor | 0.099 0.004 CID_101650225 | CID_101650225 | |
| 0.164 | 0.118 | 0.164 | Neurotrophic factor enhancer | |||
| 0.126 | 0.081 | 0.161 | Sphingosine 1-phosphate receptor 2 antagonist | 0.161 0.029 CID_101650227 | CID_101650227 | |
| 0.066 | 0.022 | 0.066 | Myc inhibitor | |||
| 0.073 | 0.029 | 0.073 | Dopamine uptake inhibitor | |||
| 0.074 | 0.031 | 0.216 | Adrenaline uptake inhibitor | 0.216 0.005 CID_101650225 | CID_101650225 | |
| 0.071 | 0.031 | 0.071 | Acetylcholine M3 receptor antagonist | |||
| 0.072 | 0.031 | 0.072 | Beta 3 adrenoreceptor antagonist | |||
| 0.048 | 0.008 | 0.073 | Benzodiazepine receptor peripheral-type antagonist | 0.073 0.004 CID_101650227 | CID_101650227 | |
| 0.081 | 0.041 | 0.081 | Lipase inhibitor | |||
| 0.089 | 0.05 | 0.089 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.151 | 0.111 | 0.151 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.074 | 0.035 | 0.074 | Potassium channel (ATP-sensitive) blocker | 0.061 0.057 CID_101650227 | ||
| 0.108 | 0.068 | 0.126 | GABA receptor agonist | 0.126 0.052 CID_101650227 | CID_101650227 | |
| 0.097 | 0.058 | 0.097 | Prolactin inhibitor | |||
| 0.076 | 0.04 | 0.076 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.045 | 0.011 | 0.045 | Sigma 2 receptor antagonist | 0.034 0.015 CID_101650227 | ||
| 0.131 | 0.098 | 0.131 | Pregnane X receptor agonist | 0.13 0.1 CID_101650227 | ||
| 0.121 | 0.09 | 0.121 | Histone deacetylase SIRT1 inhibitor | |||
| 0.039 | 0.01 | 0.039 | Urotensin II agonist | 0.031 0.014 CID_101650227 | ||
| 0.041 | 0.015 | 0.041 | Liver X receptor beta agonist | |||
| 0.061 | 0.036 | 0.061 | Ca(v)3.2 blocker | |||
| 0.045 | 0.021 | 0.051 | Substance P antagonist | 0.051 0.016 CID_101650227 0.039 0.028 CID_101650225 | CID_101650227 | |
| 0.038 | 0.014 | 0.038 | Liver X receptor beta antagonist | |||
| 0.057 | 0.034 | 0.057 | 5 Hydroxytryptamine 1 agonist | |||
| 0.053 | 0.031 | 0.071 | Neurokinin antagonist | 0.071 0.02 CID_101650227 | CID_101650227 | |
| 0.057 | 0.035 | 0.057 | Glucosylceramidase inhibitor | |||
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | |||
| 0.037 | 0.016 | 0.037 | Peptide deformylase inhibitor | |||
| 0.032 | 0.011 | 0.032 | Myristoyl transferase inhibitor | |||
| 0.045 | 0.023 | 0.049 | Neurokinin 1 antagonist | 0.049 0.02 CID_101650227 | CID_101650227 | |
| 0.054 | 0.033 | 0.054 | Neuropeptide Y5 antagonist | |||
| 0.115 | 0.094 | 0.115 | Cytokine production inhibitor | |||
| 0.049 | 0.028 | 0.049 | Oleamide hydrolase inhibitor | |||
| 0.098 | 0.078 | 0.098 | Nav1.4 sodium channel blocker | |||
| 0.06 | 0.04 | 0.06 | Bcl-xL inhibitor | |||
| 0.116 | 0.097 | 0.116 | Protein kinase C nu inhibitor | |||
| 0.081 | 0.062 | 0.088 | GABA A receptor agonist | 0.088 0.05 CID_101650227 | CID_101650227 | |
| 0.031 | 0.013 | 0.031 | Estrogen-related receptor gamma antagonist | 0.028 0.021 CID_101650227 | ||
| 0.154 | 0.137 | 0.154 | MAP kinase kinase 5 inhibitor | |||
| 0.035 | 0.018 | 0.035 | Vanilloid 4 antagonist | |||
| 0.05 | 0.034 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.021 | 0.007 | 0.021 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.03 | 0.017 | 0.03 | Sigma 1 receptor antagonist | 0.026 0.019 CID_101650227 | ||
| 0.043 | 0.031 | 0.043 | Liver X receptor agonist | |||
| 0.101 | 0.089 | 0.101 | Histone deacetylase class III inhibitor | |||
| 0.047 | 0.035 | 0.047 | Cholesterol esterase inhibitor | |||
| 0.079 | 0.069 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.044 | 0.034 | 0.044 | 5 Hydroxytryptamine 1A agonist | |||
| 0.1 | 0.091 | 0.1 | Interleukin 2 antagonist | |||
| 0.108 | 0.1 | 0.116 | Sodium channel blocker | 0.116 0.089 CID_101650227 | CID_101650227 | |
| 0.038 | 0.031 | 0.038 | Histone deacetylase 8 inhibitor | |||
| 0.047 | 0.041 | 0.047 | NMDA 2A receptor antagonist | |||
| 0.026 | 0.02 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.028 | 0.022 | 0.028 | 5 Hydroxytryptamine 6 agonist | |||
| 0.064 | 0.059 | 0.066 | Exportin-1 inhibitor | 0.066 0.052 CID_101650227 | CID_101650227 | |
| 0.163 | 0.159 | 0.163 | Calpain inhibitor | |||
| 0.062 | 0.058 | 0.108 | Protein kinase C alpha inhibitor | 0.108 0.019 CID_101650225 | CID_101650225 | |
| 0.148 | 0.145 | 0.148 | Growth factor agonist | |||
| 0.112 | 0.109 | 0.113 | Neurotrophic factor | 0.113 0.107 CID_101650227 | CID_101650227 | |
| 0.058 | 0.055 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.069 | 0.066 | 0.069 | Potassium channel (Tandem pore domain) blocker | |||
| 0.049 | 0.045 | 0.049 | 5 Hydroxytryptamine 1B agonist | |||
| 0.028 | 0.025 | 0.028 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.066 | 0.064 | 0.066 | Phospholipase D inhibitor | |||
| 0.018 | 0.016 | 0.018 | Apolipoprotein B inhibitor | |||
| 0.02 | 0.018 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.058 | 0.057 | 0.058 | 5 Hydroxytryptamine agonist | |||
| 0.092 | 0.091 | 0.092 | GABA C receptor antagonist | |||
| 0.088 | 0.099 | 0.127 | Topoisomerase II inhibitor | 0.127 0.062 CID_101650225 | CID_101650225 | |
| 0.031 | 0.044 | 0.052 | Neurokinin 2 antagonist | 0.052 0.022 CID_101650227 | CID_101650227 | |
| 0.017 | 0.032 | 0.023 | Histone deacetylase class IIb inhibitor | 0.023 0.021 CID_101650227 | CID_101650227 | |
| 0.016 | 0.032 | 0.022 | Histone deacetylase 6 inhibitor | 0.022 0.021 CID_101650227 | CID_101650227 | |
| 0.154 | 0.175 | 0.165 | 5 Hydroxytryptamine release stimulant | 0.165 0.16 CID_101650227 | CID_101650227 | |
| 0.034 | 0.058 | 0.053 | Dopamine transporter inhibitor | 0.053 0.029 CID_101650225 | CID_101650225 | |
| 0.036 | 0.063 | 0.049 | Potassium channel (Inward rectifier) blocker | 0.049 0.036 CID_101650227 | CID_101650227 | |
| 0.142 | 0.17 | 0.296 | Tumour necrosis factor alpha release inhibitor | 0.296 0.055 CID_101650227 | CID_101650227 | |
| 0.091 | 0.122 | 0.11 | Estrogen antagonist | 0.11 0.076 CID_101650225 | CID_101650225 | |
| 0.115 | 0.159 | 0.169 | Interleukin 6 antagonist | 0.169 0.065 CID_101650227 | CID_101650227 | |
| 0.055 | 0.131 | 0.094 | Topoisomerase I inhibitor | 0.094 0.075 CID_101650225 | CID_101650225 | |
| 0.047 | 0.135 | 0.085 | NMDA receptor antagonist | 0.085 0.059 CID_101650227 | CID_101650227 | |
| 0.139 | 0.228 | 0.169 | Peptidyltransferase inhibitor | 0.169 0.148 CID_101650227 | CID_101650227 | |
| 0.024 | 0.146 | 0.059 | H+/K+-transporting ATPase inhibitor | 0.059 0.026 CID_101650227 | CID_101650227 | |
| 0.043 | 0.188 | 0.072 | Viral attachment inhibitor | 0.072 0.071 CID_101650227 | CID_101650227 | |
| 0.08 | 0.238 | 0.203 | Interleukin antagonist | 0.203 0.082 CID_101650227 | CID_101650227 | |
| 0.021 | 0.222 | 0.099 | Leukotriene synthesis inhibitor | 0.099 0.027 CID_101650227 | CID_101650227 | |
| 0.05 | 0.288 | 0.224 | Interleukin 1 antagonist | 0.224 0.025 CID_101650227 | CID_101650227 | |
| 0.11 | 0.36 | 0.24 | Toll-Like receptor agonist | 0.24 0.157 CID_101650227 | CID_101650227 | |
| 0.104 | 0.378 | 0.231 | Toll-Like receptor 7 agonist | 0.231 0.166 CID_101650227 | CID_101650227 | |
| 0.014 | 0.318 | 0.09 | Check point kinase 1 inhibitor | 0.09 0.032 CID_101650225 | CID_101650225 | |
| 0.013 | 0.327 | 0.09 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.09 0.042 CID_101650225 | CID_101650225 | |
| 0.026 | 0.551 | 0.181 | Interleukin 1b antagonist | 0.181 0.024 CID_101650227 | CID_101650227 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |